Liz

What is in the reagent should be used to confirm Donor and Newborn initial D negative result?

Malcolm, when do you, and how often does it occur that you need to, quantify? Thank you,

......

I reread your post. The person did not retype the unit; I don’t see what else you are waiting for. For the sake of the patients you must take action but keep yourself safe. See the Pathologist or person in charge who you trust rather than sending emails and letters, if you do not have the authority do not document anything until asked to by a person that you trust (I repeat). If you have proof as you say then go straight to a person in authority, make sure that it’s not just hearsay (unconfirmed report).

Lots of timers!

I was inspecting your lab in the picture that you posted here!!

That would be great Malcolm, thanks, looking forward to it

Hello Malcolm, I was referring to this.

.....

What is the method that you use for quantification?

I see that you are the supervisor so you can take action openly or keep it anonymous. And in other parts of the world the standard applies as well: EU Directives During 2006, the EU Directive 2002/98/EC and Commission Directive 2005/61/EC came into force making reporting of serious adverse reactions and events relating to the quality and safety of blood components mandatory. Reporting is based on a confidential anonymous system. All blood and blood products must be traceable from donor to recipient. This information must be available for thirty years. Therefore, we have a professional responsibility and a legal obligation to adhere to these statutory requirements.

QJuli, Just inform your supervisor. It is not your fight to fight. But do inform the supervisor. "Dry" hmmm that has actually a meaning in Labs that is quite different from yours.

Great, for sure we shall meet!

Exactly Jeanne, there are no agency regulations it depends on your facility requirements. I for one like red but I stopped because our Quality Officer may decide against it and I do not want to re - sign. I prefer blue to black to differentiate from photocopied material.

It is awfully time consuming, but what happened to make you say that it doesnt work?

Oh I am very happy!!!! Great news Malcolm. See you there!!!

Dear Immucor automation users, I am planning on acquiring the Neo, what is your opinion? Bio-Rad has also presented a tender and we are currently using the maual BioRad, is it smart to move to solid phase? And what is your current manual backup, solid phase or gel? Thank you so much!!

Does anyone use the Immucor Neo and can you tell me the problems that you are facing? Thank you

what kind of problem exactly?

We will all be there Malcolm!!!!! Boston!!! not too far.

I enjoyed the following topics: Blood Management Biovigilance Iron overload Stem Cell Top Gun Serology And many, many others!! As well as the Posters on the RBC antigens and antibodies. And the Exhibit! I was so sorry that I could not meet up with the BB talk group. I was planning on what to wear to be noticed but the unexpected happened as usual and I had to meet with local colleagues who also planned lunch, "no" was not an option. Hopefully, next year in Boston I can meet the wonderful people I communicate with here. Kind regards and until next time.:flirty: Liz

We were dropped by Baxter (Fenwal) as the rest of the world... so nothing personal, then we were very pleased with Milteny but ...but ... oh but the regional rep is giving a hard time to the local rep so they stopped and I am moving to OriGen, presently shall start validation. Thanks for the good news about it!

Exactly, it is when you introduce the antibody to a person rather than have them form it, which would be active formation of the antibody. I too feel that your question is more loaded than this answer. You can elaborate if you wish and we'll give it another shot.

Thank you, does anyone mind sharing an example of their written procedure on how to validate.

Routine DAT testing is not required.